Literature DB >> 32353068

Maternal visceral adipose tissue during the first half of pregnancy predicts gestational diabetes at the time of delivery - a cohort study.

Alexandre da Silva Rocha1, Juliana Rombaldi Bernardi2, Salete Matos3, Daniela Cortés Kretzer3, Alice Carvalhal Schöffel4, Marcelo Zubaran Goldani5, José Antônio de Azevedo Magalhães6.   

Abstract

BACKGROUND: Gestational diabetes mellitus (GDM) is a common condition, often associated with high maternal and fetal morbidity. The use of new tools for early GDM screening can contribute to metabolic control to reduce maternal and fetal risk. This study aimed to ascertain whether maternal visceral adipose tissue (VAT) measurement by ultrasound during the first half of pregnancy can predict the occurrence of GDM during the third trimester.
METHODS: A prospective cohort study of 133 pregnant women with gestational age ≤20 weeks in an outpatient setting. VAT depth was measured by ultrasound at the maternal periumbilical region. GDM status was obtained through hospital charts during hospitalization to delivery. A Receiver Operator Characteristic (ROC) curve was used to determine the optimum threshold to predict GDM.
RESULTS: According to the ROC curve, a 45mm threshold was identified as the best cut-off value, with 66% of accuracy to predict GDM. Crude and adjusted odds ratios (OR) for GDM were 13.4 (95%CI 2.9-61.1) and 8.9 (95%CI 1.9-42.2), respectively. A similar result was obtained among pre-gravid non-obese women, with crude and adjusted OR of 16.6 (95%CI 1.9-142.6) and 14.4 (95%CI 1.7-125.7), respectively. Among pre-gravid obese patients, a 45mm threshold did not reach statistical significance to predict GDM.
CONCLUSION: The high and significant OR found before and after adjustments provides additional evidence of a strong association between VAT and GDM. It appears that VAT measurement during the first half of pregnancy has great potential in identifying non-obese women at high risk for GDM. This evidence can assist obstetricians in correctly allocating resources among populations of pregnant women at risk, determined not only by pre-gravid body mass index (BMI).

Entities:  

Year:  2020        PMID: 32353068     DOI: 10.1371/journal.pone.0232155

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  5 in total

Review 1.  Gestational Diabetes Mellitus and Maternal Immune Dysregulation: What We Know So Far.

Authors:  Colm J McElwain; Fergus P McCarthy; Cathal M McCarthy
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

2.  High Frequency of Fetal Loss in Fetuses With Normal Karyotype and Nuchal Translucency ≥ 3 Among the Iranian Pregnant Women.

Authors:  Shokoh Abotorabi; Niloufar Moeini; Sahar Moghbelinejad
Journal:  J Family Reprod Health       Date:  2020-06

3.  Association of body composition in early pregnancy with gestational diabetes mellitus: A meta-analysis.

Authors:  Fatemeh Alsadat Rahnemaei; Fatemeh Abdi; Reza Pakzad; Seyedeh Hajar Sharami; Fatemeh Mokhtari; Elham Kazemian
Journal:  PLoS One       Date:  2022-08-15       Impact factor: 3.752

4.  Gestational diabetes mellitus screening in pandemic times: Are there viable alternatives?

Authors:  Alexandre da Silva Rocha; Juliana Rombaldi Bernardi; Salete de Matos; Daniela Cortés Kretzer; Alice Carvalhal Schöffel; Felipe Moretti; José Antônio de Azevedo Magalhães
Journal:  Aust N Z J Obstet Gynaecol       Date:  2020-10       Impact factor: 2.100

5.  Anthropometrical measurements and maternal visceral fat during first half of pregnancy: a cross-sectional survey.

Authors:  Daniela Cortés Kretzer; Salete Matos; Lisia Von Diemen; José Antônio de Azevedo Magalhães; Alice Carvalhal Schöffel; Marcelo Zubaran Goldani; Alexandre da Silva Rocha; Juliana Rombaldi Bernardi
Journal:  BMC Pregnancy Childbirth       Date:  2020-09-29       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.